Liponorm F Tablet is a combination lipid-lowering medication containing Atorvastatin 10 mg and Fenofibrate 160 mg, formulated to manage dyslipidemia and reduce cardiovascular risk in patients with mixed hyperlipidemia. Atorvastatin, a potent HMG-CoA reductase inhibitor, effectively lowers low-density lipoprotein cholesterol (LDL-C), total cholesterol, and triglycerides while modestly increasing high-density lipoprotein cholesterol (HDL-C). Fenofibrate, a fibric acid derivative, primarily reduces triglyceride levels and elevates HDL-C by activating peroxisome proliferator-activated receptor alpha (PPARα), enhancing lipolysis and elimination of triglyceride-rich particles. The synergistic action of these agents provides comprehensive lipid control, particularly beneficial in patients with elevated triglycerides and LDL-C refractory to monotherapy. Liponorm F is indicated for adults with mixed dyslipidemia, diabetic dyslipidemia, or those at high risk of cardiovascular events due to lipid abnormalities. It should be used as an adjunct to diet and lifestyle modifications, including exercise and weight control. Caution is advised in patients with hepatic or renal impairment, and regular monitoring of liver enzymes, renal function, and muscle symptoms is recommended to detect potential adverse effects such as myopathy or hepatotoxicity. Liponorm F should be prescribed under medical supervision with appropriate clinical evaluation.